2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Ken W. Batchelor, PhD

President and CEO
NovaTarg Therapeutics
2 Davis Drive
Research Triangle Park, NC
USA 27709

Papers:
42 The effects of NT1014, a novel AMPK activator, compared to metformin, on ovarian cancer cell proliferation, apoptosis, and tumor growth